Thioplan 15 mg Thiotepa Injection (1 vial)

At a Glance

Generic Name: Thiotepa

Brand Name: Thioplan 15 mg

Strength & Pack Size: 15 mg thiotepa per vial, 1 single-use vial

Dosage Form & Route: Lyophilised powder for solution for IV infusion or intracavitary use as per protocol

Therapeutic Class: Alkylating agent cytotoxic chemotherapy (polyfunctional aziridine)

Primary Indications: Selected solid tumours, haematologic malignancies, intravesical therapy and conditioning for stem cell transplantation, depending on local approvals

Typical Use in Therapy: Used in combination regimens designed by transplant, haematology or oncology specialists

Mode of Action: Cross-links DNA and interferes with DNA synthesis and cell division in rapidly dividing cells

Key Benefits: Option within established high-risk or specialised regimens where thiotepa forms part of the protocol

Precautions: Strict cytotoxic handling with intensive monitoring for myelosuppression, mucositis, organ toxicity and fertility impact

Storage: Store as directed on the product carton, usually below 25 °C, protected from light and moisture in the original outer carton

Product Description

Thioplan 15 mg contains thiotepa, a well-known alkylating cytotoxic agent used in selected oncology and transplant settings. Each vial provides 15 mg of thiotepa as a lyophilised powder that must be reconstituted by trained staff before administration. Thioplan 15 mg thiotepa injection is reserved for situations where an experienced oncology, haematology or transplant team has decided that thiotepa is an appropriate component of the treatment regimen and can be delivered safely with full supportive care.

Depending on local product information and clinical practice, thiotepa injection may be used as part of conditioning regimens prior to haematopoietic stem cell transplantation, in certain solid tumours, or via intracavitary or intravesical routes for selected indications. Because thiotepa is a potent alkylating agent with predictable and sometimes profound myelosuppression and mucosal toxicity, it is not a routine outpatient medicine. Thioplan 15 mg thiotepa injection is handled exclusively in hospitals or specialist centres with the facilities to manage high-dose chemotherapy or complex multimodal regimens.

Generic Meds Mart supplies Thioplan 15 mg thiotepa injection in original, sealed oncology packaging sourced from licensed manufacturers and authorised distributors. Vials are shipped in neutral outer cartons without obvious references to cancer types or thiotepa on the shipping label, helping to preserve patient privacy. Batch numbers and expiry dates remain clearly visible on the primary pack so hospital pharmacies can document and verify each vial before inclusion in a chemotherapy protocol. Prices are shown in USD to support transparent planning for intensive or high-cost treatment courses.

Key Uses

In practice, Thioplan 15 mg thiotepa injection is used in specialised indications defined by regional approvals, product information and institutional protocols. Examples may include selected solid tumours, combination regimens for haematologic malignancies and conditioning regimens for autologous or allogeneic stem cell transplantation when thiotepa is part of an established protocol. In some settings, thiotepa may also be used by intracavitary or intravesical routes for local control of specific malignancies, always under direct specialist supervision.

The decision to use thiotepa instead of or alongside other alkylating agents, platinum compounds, anthracyclines, antimetabolites or targeted therapies is highly individualised. It depends on prior lines of therapy, organ function, performance status, anticipated transplant strategy and access to supportive care. Thioplan 15 mg thiotepa injection is never a first point of contact treatment and is only introduced once a comprehensive plan has been documented by the multidisciplinary team.

How Thiotepa Works in Chemotherapy

Thiotepa, the active ingredient in Thioplan 15 mg injection, is a polyfunctional alkylating agent of the aziridine group. After administration, thiotepa and its active metabolites can form highly reactive ethyleniminium intermediates that attack nucleophilic sites on DNA. By alkylating DNA strands, thiotepa causes intra-strand and inter-strand cross-links that interfere with replication and transcription and ultimately trigger cell death in rapidly dividing cells.

Like other alkylating agents, thiotepa is not cell cycle–specific, but its cytotoxic effects are most pronounced in tissues with high proliferative activity, such as bone marrow, gastrointestinal mucosa and many tumours. When used as part of high-dose conditioning regimens before stem cell transplantation, thiotepa contributes to intensive myeloablation and immunosuppression, which helps eradicate malignant cells and create space for engraftment of transplanted stem cells. In lower-dose or local applications, thiotepa can exert cytotoxic effects at or near the tumour site according to the treatment protocol.

Because of its broad impact on proliferating tissues, thiotepa demands experienced supportive care, including infection prophylaxis, transfusion support, nutritional management and careful monitoring of organ function. The balance between antitumour efficacy and toxicity is managed on a case-by-case basis by specialists familiar with thiotepa-based regimens.

Dosage & Administration

Thioplan 15 mg thiotepa injection must only be prescribed and administered by physicians experienced in high-dose chemotherapy, stem cell transplantation or specialised oncologic protocols. Each vial contains 15 mg thiotepa powder that must be reconstituted with a compatible diluent and, if required, further diluted in infusion fluid according to the manufacturer’s instructions and local pharmacy procedures. Vials are strictly for single use, and reconstituted solutions must be handled as cytotoxic preparations.

Doses of thiotepa are usually calculated based on body weight or body surface area and vary widely depending on indication, route of administration, combination partners and transplant strategy. Regimens may involve single or multiple doses over one or more days, often with additional conditioning agents or systemic chemotherapy. Thioplan 15 mg thiotepa injection is never self-administered; it is given intravenously, intravesically or via a controlled intracavitary route in a hospital setting where resuscitation equipment, protective isolation and experienced nursing care are available.

Patients receiving thiotepa typically require central venous access, strict fluid and electrolyte management, concurrent prophylaxis against infections and mucositis, and frequent blood tests to monitor marrow suppression and organ function. Any dose changes, delays or cessation of therapy are determined exclusively by the treating team, based on a detailed risk–benefit assessment and real-time clinical data.

Precautions

Before Thioplan 15 mg thiotepa injection is included in a regimen, the treatment team performs a comprehensive review of medical history, previous chemotherapy or radiotherapy, organ function (especially liver, kidney, heart and lungs), infection risk and fertility considerations. Thiotepa is known to cause profound myelosuppression, so patients must have frequent full blood counts, and access to transfusion support and growth factors is often required.

Thiotepa can cause significant mucosal and skin toxicity, including oral mucositis, gastrointestinal irritation and skin eruptions or hyperpigmentation, especially in high-dose or transplant-conditioning settings. Careful skin hygiene, mouth care and avoidance of prolonged skin contact with excreta containing thiotepa metabolites are advised, as directed by local protocols. Fertility may be permanently affected, and discussions about sperm banking or other fertility preservation measures typically take place before treatment. Thioplan 15 mg thiotepa injection is contraindicated in pregnancy and should not be handled or administered by pregnant staff without appropriate protective measures.

Thiotepa Side Effects

Common side effects

Common thiotepa side effects of Thioplan 15 mg thiotepa injection reflect its alkylating mechanism and impact on rapidly dividing tissues. These may include myelosuppression with neutropenia, thrombocytopenia and anaemia; fatigue; hair thinning or alopecia; nausea and vomiting; decreased appetite; oral mucositis; diarrhoea or constipation; and mild skin changes such as dryness or hyperpigmentation. Many patients report a general feeling of weakness during and after intensive cycles, which may persist until marrow and mucosal tissues recover.

With appropriate supportive care, many of these common thiotepa side effects can be anticipated and managed. Antiemetic regimens, mouthwashes, nutritional support, transfusions and growth factor support are examples of standard measures used in centres that routinely deliver thiotepa-based chemotherapy or conditioning.

Serious side effects

Serious thiotepa adverse effects of Thioplan 15 mg thiotepa injection require immediate medical attention and may be life-threatening. These can include severe and prolonged bone marrow suppression with high risk of sepsis or major bleeding; severe mucositis with inability to swallow or maintain nutrition; severe diarrhoea with dehydration; organ toxicity such as hepatic dysfunction or renal impairment; neurotoxicity in high-dose settings; and severe skin toxicity. There is also a risk of secondary malignancies with many alkylating agents when used over the long term, although this risk must be weighed against the underlying disease risk.

Patients and caregivers are instructed to contact the treatment centre urgently if there is fever, chills, uncontrolled bleeding, severe mouth pain, inability to eat or drink, reduced urine output, confusion, jaundice, severe breathlessness or any other alarming symptom during or after thiotepa treatment. The managing team may need to adjust ongoing therapy, intensify supportive care or consider alternative strategies, depending on the clinical scenario.

Storage

Thioplan 15 mg thiotepa injection vials should be stored as specified on the product carton and in the accompanying leaflet, usually below 25 °C and protected from light and moisture in the original outer carton. Vials must be kept out of reach of children and should not be used after the expiry date. Reconstituted solutions have limited stability and must be prepared and used according to local cytotoxic preparation guidelines. Unused solution, vials and administration materials should be disposed of as cytotoxic waste, following institutional and regulatory requirements.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on structured access to important oncology and transplant-supportive medicines such as Thioplan 15 mg thiotepa injection. We partner only with licensed manufacturers and authorised distributors that comply with Good Manufacturing Practice and maintain full batch traceability. Each vial of Thioplan 15 mg is supplied in sealed original packaging, allowing hospital pharmacies to verify manufacturer, strength, batch number and expiry before release to the chemotherapy or transplant unit.

By listing Thioplan 15 mg thiotepa injection in USD, Generic Meds Mart helps treatment centres and patients plan for the cost of complex regimens that may require multiple vials across several cycles. Neutral shipping cartons protect confidentiality, while tracking (where available) allows coordination between delivery and treatment scheduling. Our support team can help with ordering and logistics questions, but we do not interfere in clinical decisions; the entire responsibility for choosing thiotepa and designing regimens remains with the treating specialists.

Order Now

Thioplan 15 mg thiotepa injection is a potent hospital-only cytotoxic medicine and must never be ordered for unsupervised use. Before arranging supply through Generic Meds Mart, the patient’s oncology or transplant team should have confirmed the indication, thiotepa’s role in the regimen, the required dosing scheme, the number of vials needed per cycle and the overall schedule. They should also have verified that the centre has the infrastructure to deliver thiotepa safely, including cytotoxic handling facilities, isolation capabilities and comprehensive supportive care.

Once the plan is in place, the team or designated purchaser can calculate how many vials of Thioplan 15 mg injection are required for the initial phase of treatment. They can then select the relevant quantity on Generic Meds Mart, add it to the cart and complete secure checkout in USD. Medicines are shipped in discreet outer packaging with full original labelling inside. Patients and caregivers should never attempt to reconstitute or administer thiotepa themselves, and any concerns about side effects or dosing must be discussed promptly with the specialist team overseeing care.

FAQ about Thioplan (Thiotepa)

Q1: What is Thioplan 15 mg used for?
Thioplan 15 mg contains thiotepa, an alkylating cytotoxic agent used under specialist supervision in selected solid tumours, haematologic malignancies, intravesical or intracavitary therapy and conditioning regimens for stem cell transplantation, according to local product information and institutional protocols.

Q2: Can Thioplan 15 mg be given outside a hospital?
Thioplan 15 mg thiotepa injection is not designed for home use. It is reconstituted and administered in hospital or specialist centres with trained staff, cytotoxic preparation facilities and the ability to provide intensive monitoring and supportive care, especially when used in high-dose or transplant-conditioning regimens.

Q3: How is Thioplan 15 mg administered?
Depending on the protocol and indication, Thioplan 15 mg thiotepa injection may be administered intravenously as part of systemic chemotherapy or conditioning, or via controlled intracavitary or intravesical routes. The exact route, dose and schedule are defined by the treating team and must follow the official product information and institutional guidelines.

Q4: What monitoring is needed during thiotepa treatment?
Patients receiving Thioplan 15 mg thiotepa injection require frequent blood counts, monitoring of liver and kidney function, assessment of mucosal and skin toxicity, infection surveillance and close clinical review. In transplant settings, monitoring may be even more intensive, with detailed haemodynamic, organ function and engraftment assessments.

Q5: Can Thioplan 15 mg affect fertility?
Like many alkylating agents, thiotepa can impair fertility, and the effect may be permanent in some patients. The treating team often discusses fertility preservation options such as sperm banking before starting Thioplan 15 mg thiotepa injection, especially in younger patients or those for whom future fertility is a priority.

Celplat 50 mg/50 mL Cisplatin Injection (1 pack / 1 vial)

At a Glance

Generic Name: Cisplatin

Brand Name: Celplat

Strength & Pack Size: 50 mg/50 mL (1 mg/mL) solution; 1 pack / 1 vial

Dosage Form & Route: Sterile solution for IV infusion after dilution (hospital/clinic use)

Therapeutic Class: Platinum-based antineoplastic (alkylating-like chemotherapy)

Primary Indication: Testicular, ovarian, and bladder cancers where cisplatin-based regimens are appropriate

Typical Use in Therapy: Given in cycles, often as part of combination chemotherapy under oncology supervision

Usual Adult Dose: Individualised by protocol and specialist; dosing depends on body surface area, kidney function and regimen

Prescription Status: Prescription-only, administered by healthcare professionals

Storage: Store as directed on the vial/carton; protect from light and keep out of reach of children

Product Description

Celplat 50 mg/50 mL contains cisplatin, a platinum-based anticancer medicine used in multiple solid tumours. This presentation provides 1 pack / 1 vial containing 50 mg of cisplatin in 50 mL solution, designed for dilution and intravenous infusion in a clinic or hospital setting. Cisplatin is not a home-use medicine and should only be used when there is a confirmed diagnosis and a treatment plan created by an oncology team.

Cisplatin is widely used because it can be an effective backbone drug in combination regimens. Depending on local guidelines and your individual case, cisplatin may be part of protocols for testicular cancer, ovarian cancer, and bladder cancer, and it may also be used in certain settings for cervical cancer, head and neck cancers, or lung cancer when a cisplatin-based approach is clinically indicated. The exact regimen, combination partners and cycle timing are defined by your treating oncologist, not by self-selection.

Generic Meds Mart supplies Celplat cisplatin injection in original manufacturer packaging sourced through licensed channels. The carton and vial typically show the brand name, active ingredient, strength/concentration, batch number and expiry date to support verification by hospital pharmacies and infusion centres. Orders are shipped in discreet outer packaging to protect privacy, and delivery options may include tracking where regulations allow. Generic Meds Mart supports access and logistics only; all decisions about cisplatin use, cisplatin dosage and monitoring remain with your treating specialists.

Key Uses

Celplat cisplatin injection is commonly used in testicular cancer combination chemotherapy, including protocols where cisplatin is a key component under specialist supervision. Treatment intent and schedule are determined by your oncology team based on tumour type, stage and response assessment.

Celplat may also be used in ovarian cancer regimens, including combination treatment plans where platinum therapy is appropriate according to local standards and prior therapy history. Your specialist will consider previous exposure to platinum drugs, overall treatment goals and expected tolerability before selecting a cisplatin-based regimen.

In bladder cancer, cisplatin-based chemotherapy is often considered for eligible patients, including in neoadjuvant settings or in advanced disease, depending on kidney function, performance status and other clinical factors. Because cisplatin can be intensive and requires close monitoring, eligibility is individualised and alternatives may be considered when standard cisplatin dosing is not suitable. In some protocols, cisplatin is also used with radiotherapy in cervical cancer or head and neck cancers, but such use must follow specialist guidance and local regulations.

How Cisplatin Works in Chemotherapy

Cisplatin works mainly by forming platinum–DNA adducts inside cells. After administration, cisplatin becomes activated and binds to DNA, creating cross-links within and between DNA strands. These cross-links disrupt DNA replication and transcription, triggering cell-cycle arrest and apoptosis, particularly in rapidly dividing cancer cells.

Because cisplatin affects fundamental DNA processes, it can be active across multiple tumour types, especially when combined with other anticancer agents that damage cells through complementary mechanisms. The same DNA-damaging activity can also affect healthy tissues, which is why oncology teams use supportive care, careful dosing and monitoring to reduce risks while maintaining treatment effectiveness.

Dosage & Administration

Celplat cisplatin injection is administered only by healthcare professionals. The vial is typically diluted into an appropriate infusion fluid and given intravenously over a time period specified by the protocol. Dosing is individualised and may be calculated by body surface area, kidney function, blood counts and the specific combination regimen being used. Treatment is usually delivered in cycles with rest periods between cycles, and dose adjustments may be required based on side effects and laboratory results.

Hydration and electrolyte management are important parts of cisplatin administration because kidney toxicity is a key risk. Many protocols include pre- and post-infusion IV fluids and may include magnesium or potassium supplementation. Antiemetic medicines are usually given to reduce nausea and vomiting. Never self-adjust a cisplatin regimen and do not attempt to use this medicine outside a clinic setting. If an infusion is delayed or a cycle is missed, your oncology team will decide how to adjust the schedule safely.

Precautions

Cisplatin can cause significant kidney toxicity, so kidney function tests are routinely monitored before and during therapy. Patients with reduced kidney function may not be eligible for standard cisplatin dosing, and alternatives may be considered by the oncologist. Cisplatin can also cause severe nausea and vomiting without appropriate prevention, so antiemetic plans are essential.

Blood counts may drop during therapy, increasing the risk of infections and bleeding. Report fever, chills, sore throat, easy bruising or unusual bleeding promptly. Cisplatin may cause peripheral neuropathy and hearing-related effects such as tinnitus or hearing loss, which can be cumulative. Tell your team about numbness, tingling, balance changes, ringing in the ears or any hearing changes as early reporting helps clinicians assess risk and adjust treatment when needed.

Electrolyte disturbances such as low magnesium or potassium can occur and may require replacement. Infusion-site reactions and tissue injury can occur if cisplatin leaks outside the vein, so infusions should be administered with appropriate IV access and close observation. Cisplatin is harmful in pregnancy and can affect fertility; discuss contraception and fertility planning with your specialist before treatment. Always share a complete list of medicines and supplements with your oncology team, especially drugs that may affect kidneys or hearing, so overlapping toxicities and interactions can be managed.

Cisplatin Side Effects

Common side effects

Common cisplatin side effects include nausea and vomiting, loss of appetite, fatigue, taste changes and temporary changes in blood counts. Some patients experience constipation or diarrhoea, mouth soreness and transient changes in kidney tests monitored by the clinic. Tingling in the hands or feet, mild numbness or ringing in the ears can occur, especially as cumulative doses increase. Injection-site discomfort may occur during infusion and should be reported to staff.

Serious side effects

Serious side effects require urgent medical attention and may include significant reduction in kidney function, decreased urine output, swelling or severe electrolyte abnormalities. Severe infections due to low white blood cells, uncontrolled bleeding due to low platelets or severe anaemia can occur and may require hospital care. Hearing loss, persistent or worsening neuropathy, severe allergic or infusion reactions and severe uncontrolled vomiting or dehydration are also serious concerns. If you develop high fever, severe shortness of breath, chest pain, confusion, fainting, heavy bleeding, black stools, rapidly worsening weakness or markedly reduced urination, seek urgent care and tell clinicians you are receiving cisplatin.

Storage

Celplat cisplatin vials should be stored according to the instructions printed on the vial and carton, protected from light and kept in the original packaging until use. Storage, dilution and handling are typically managed by hospital pharmacy services following cytotoxic safety procedures. Do not use the product after the expiry date, and ensure unused medicine or materials are disposed of as hazardous pharmaceutical waste according to local regulations. Patients are not usually expected to store cisplatin at home; if transport is required, follow the clinic’s written instructions.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for oncology medicines such as Celplat cisplatin injection. We supply products in original packaging from licensed sources with batch and expiry information visible for verification by pharmacies and clinics. Pricing is shown in USD, and orders can be placed through secure checkout.

Where regulations allow, shipments are sent in discreet outer packaging with tracking options to help coordinate delivery with chemotherapy schedules and appointments. Generic Meds Mart does not provide individual medical advice or determine chemotherapy regimens. Decisions about whether cisplatin is appropriate, the correct dose and how to manage side effects must be made by your treating oncology team.

Order Now

Before you buy Celplat 50 mg/50 mL cisplatin injection online from Generic Meds Mart, make sure your oncologist has confirmed that a cisplatin-based regimen is appropriate and has specified the required dose, cycle schedule and monitoring plan. Your clinic will also confirm kidney function, blood counts, hydration strategy and supportive medicines such as antiemetics before each cycle.

Once your treatment plan is confirmed, select Celplat 50 mg/50 mL (1 pack / 1 vial), choose the quantity needed for the planned cycles and complete secure checkout in USD. Orders are supplied in original packaging with discreet delivery options where permitted, but do not attempt to administer cisplatin yourself or modify the schedule without specialist guidance. For questions about cisplatin dosage, cisplatin side effects or missed cycles, contact your treating oncology team.

FAQ about Celplat (Cisplatin)

Q1: What is Celplat 50 mg/50 mL used for?

Celplat contains cisplatin, a platinum-based chemotherapy medicine used in several solid tumours. It is commonly included in regimens for testicular, ovarian and bladder cancers when prescribed by an oncologist.

Q2: Is Celplat given as a quick injection or an infusion?

Celplat is typically diluted and given by intravenous infusion under clinical supervision. The infusion time and dilution method depend on the protocol used by your oncology team.

Q3: Why are hydration and blood tests important with cisplatin?

Hydration helps reduce kidney toxicity risk, and blood tests monitor kidney function, electrolytes and blood counts. These checks help clinicians adjust treatment and manage side effects safely.

Q4: What should I do if I feel tingling or notice hearing changes?

Tell your oncology team promptly if you develop numbness, tingling, ringing in the ears or hearing changes. These symptoms may indicate cisplatin-related nerve or hearing effects that require assessment.

Q5: Can I take other medicines during cisplatin treatment?

Many patients take supportive medicines during treatment, but interactions and overlapping toxicities are important. Provide your oncologist and pharmacist with a full list of medicines and supplements so they can advise what is safe with your regimen.